indium has been researched along with Mast-Cell Sarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunda, MJ; Gorelik, E; Herberman, RB; Holden, HT; Wiltrout, RH | 1 |
Adams, DO; Mastin, JP; Somers, SD | 1 |
Cummings, GD; Frost, P; Wiltrout, RH | 1 |
3 other study(ies) available for indium and Mast-Cell Sarcoma
Article | Year |
---|---|
Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.
Topics: Animals; Chromium; Chromium Radioisotopes; Female; Hydroxyquinolines; Idoxuridine; Immunity, Innate; Indium; Iodine Radioisotopes; Lymphocytes; Lymphoma; Mast-Cell Sarcoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Organometallic Compounds; Oxyquinoline; Radioisotopes; T-Lymphocytes; Tissue Distribution | 1983 |
The binding of tumor cells by murine mononuclear phagocytes can be divided into two qualitatively distinct types.
Topics: Animals; Binding Sites; Binding, Competitive; Cell Transformation, Neoplastic; Edetic Acid; Indium; Macrophage Activation; Macrophages; Mast-Cell Sarcoma; Mice; Mice, Inbred A; Mice, Inbred C57BL; Radioisotopes; Trypsin | 1983 |
Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays.
Topics: Animals; Cell Line; Chromium Radioisotopes; Cytotoxicity Tests, Immunologic; Female; Indium; Kinetics; Mast-Cell Sarcoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Radioisotopes; Sarcoma, Experimental; Time Factors | 1978 |